German biotech company HMNC Brain Health raises €9M

Mobi Health News

The funds will be used to accelerate HMNC’s pipeline development towards market maturity

UC Riverside’s Wet Lab Incubator Open To Biotech Entrepreneurs

Electronic Health Reporter

UC Riverside’s Wet Lab Incubator has opened its doors to biotech entrepreneurs throughout the Inland Empire. The article UC Riverside’s Wet Lab Incubator Open To Biotech Entrepreneurs appeared first on electronichealthreporter.com. Editorial Biotech Murrieta Genomics Rodolfo Torres UC Riverside’s Wet Lab IncubatorThis article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UK biotech company Theolytics raises £5M in Series A funding

Mobi Health News

The company will expand its oncolytic viral therapy platform to combat cancer

Psychedelic biotech company scoops up research focused digital health company HealthMode

Mobi Health News

MindMed plans to use HealthMode's machine learning capabilities into its new digital medicine division.

Modernizing Pharmaceutical Supply Chains

Speaker: Nimesh Patel, Gregory Demitrack, and Sarah Barnes Humphrey

Register for our upcoming webinar to better understand the state of the pharmaceutical supply chain. FourKites partnered with Accenture to survey supply chain executives working in pharmaceuticals, biotech, cell and gene therapy, medtech, and other related industries.

Benchling gets $14.5M to build collaboration tools for biotechs, pharmas

Mobi Health News

Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional participation by F-Prime Capital and returning investor Thrive Capital

Pfizer to Grant Golden Tickets to Biotech Startups

MedTech Boston

The post Pfizer to Grant Golden Tickets to Biotech Startups appeared first on MedTech Boston. News biotech startups Boston Biotech labcentral pfizerIt might be your lucky day. Pfizer has issued a call for U.S. startup companies to file proposals to.

China’s Burning Rock Biotech completes Series C financing of RMB 850 million

Mobi Health News

Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital

New from Tech Tonics: Andrew Trister: From Jersey Boy to Digital Doc

Digital Health

With a knack for engineering and a passion for patients, Dr. Andrew Trister’s career has taken this Jersey boy from radiation oncology to Apple to his current role at the Gates Foundation, where he’s spearheading their efforts to leverage technology to improve the health of people around the world.

Latest from Tech Tonics: Takeda’s Ariel Dowling: An Engineer With A Passion For Digital Health

Digital Health

Digital Health Healthcare Information Technology Pharma/Biotech Sensors & Wearables Tech Tonics Podcast Uncategorized Ariel Dowling connected social media david shaywitz Lisa Suennen Manatt Health MC10 Takeda Data Science Institute Takeda Pharma tech tonics podcast wearables

New Tech Tonics Podcast Episode: Sean Khozin: Attuned To Data Science

Digital Health

Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin

Space-bound Billionaires Can Help Make the World a Healthier Place Through Research

Digital Health

Biotech and Genetics Digital Health Entrepreneurship Healthcare Innovation Real Science Sensors & Wearables astronaut health research in space Space Health SpaceX Inspiration4 Translational Research Institute for Space Health TRISH

Biotech billionaire Patrick Soon-Shiong steps down from ONC health IT advisory committee

FierceHealthIT

the biotech billionaire and CEO of health technology company NantWorks, on Wednesday said that he is stepping down from the federal Health IT Advisory Committee (HITAC) that provides policy recommendations to the Office of the National Coordinator for Health IT Patrick Soon-Shiong, M.D.,

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

The one segment which has stayed relatively even from 2018 has been biotech, 55% that year and 55% again in 2021. You’re stressed, I’m stressed; most of us have felt stress in the COVID-19 era which began in the U.S. in the first quarter of 2020.

New Tech Tonics Podcast – Carolyn Magill – May the Fast, Steep Road Rise Up to Meet You!

Digital Health

Biotech and Genetics David Shaywitz Digital Health Entrepreneurship Healthcare Information Technology Innovation Pharma/Biotech Uncategorized Aetion Carolyn Magill connected social media david shaywitz evolent Lisa Suennen tech tonics podcastCarolyn Magill had planned a life in foreign service or international relations. But it wasn’t until she found herself at the nexus of healthcare and public policy that she realized she found her home.

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? Getting totally rid of the coronavirus isn’t likely, so we humans must accept the fact that SARS-CoV-2 will be endemic.

New Tech Tonics Episode: Susan Desmond-Hellmann: The Inquisitive Leader

Digital Health

Her illustrious career has taken her from clinician to biotech executive to university chancellor to CEO of the world’s largest foundation, yet throughout this exceptional journey, Susan Desmond-Hellmann has remained empathetic, inquisitive, and emphatically true to herself.

The Race for Optimum Insulin Control – Artificial Intelligence vs. Biotech

Insulin Nation

Managing blood glucose is difficult even with the current array of insulin options. Rapid-acting and long-lasting analogues still feature the steep dose-response curve that is the key shortcoming of conventional insulin. That makes for the fine line between an effective dose and one that sends blood glucose levels too low … ‘ said Harry Destecroix, CEO of Ziylo, which was just acquired by Novo Nordisk. Industry leaders are pursuing two paths for achieving better insulin control.

Healthcare, Heal Thyself! How the Industry Can and Should Play the Trust Card

Health Populi

The emergence of the COVID-19 vaccine “infodemic” has slowed the ability for nations around the world to emerge out of the public health crisis.

I Want a New Drug, Part 2 –Digital Therapeutics on the Rise

Digital Health

Digital Health Entrepreneurship Healthcare Information Technology Healthcare Venture Capital Innovation Pharma/Biotech Precision Medicine Uncategorized AppliedVR Beth Rogozinski Congnivive digital drug digital medicine digital therapeutics freespira Otsuka Proteus Pear Therapeutics Tony Simon welldocIn the last month I have spoken at an event about digital therapeutics and been invited to speak at 5 more unrelated events on the same topic (note: I am not doing them all).

NYU Langone opens NYC's largest biotech incubator with backing from biopharma giants

FierceHealthIT

NYU Langone Health opened a 50,000 square-foot biotech incubator space in Manhattan that has attracted big-name corporate sponsors including biopharma giants Bristol-Myers Squibb, Sanofi, and Boehringer Ingelheim. The health system's biotech incubator is part of a larger effort by New York City and the state of New York to turn the city into a top-tier biopharma hub after years of lagging behind Boston/Cambridge, MA, and the San Francisco Bay Area

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

COVID-19 is re-shaping all industries, especially health care. And the pharma industry is challenged along with other health care sectors.

New Tech Tonics Podcast: From Maine to Mainstream: The Noah Craft Story

Digital Health

Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Pharma/Biotech Tech Tonics Podcast connnected social media david shaywitz Lisa Suennen noah craft Sceince37 Science 37 siteless clinical trial Tech Tonics tech tonics podcst virtual clinical trial

New Tech Tonics Episode: Imran Haque – Grounded Data Scientist

Digital Health

Biotech and Genetics Diagnostics and Screening Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast computational biologist connected social media Counsyl david shaywitz Freenome Imran Haque Lisa Suennen Tech Tonics tech tonics podcastA computational biologist by training, Imran Haque has managed to achieve the near-impossible: embracing the promise of data science in medicine while retaining his critical faculties.

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

Health Populi

The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue).

New Tech Tonics Episode: Katherine Chou: How A Quintessential Googler Wraps Her (Deep) Mind Around Healthcare

Digital Health

Biotech and Genetics David Shaywitz Diagnostics and Screening Digital Health Healthcare Information Technology Innovation Tech Tonics Podcast Uncategorized connected social media david shaywitz dnanexus Google Deep Mind Google Medical Brain Katherine Chou Lisa SuennenKatherine Chou is in many ways the quintessential Googler – super smart, a passion for computer science, an engineer through and through.

Moderna, one of the biggest gambles in Biotech history to be tested on Wall Street with $10Bn IPO

Lloyd Price

One of the biggest gambles in biotech history is about to be tested on Wall Street. In its prospectus, Moderna set an initial target of $500 million for the offering, which would make it the largest biotech IPO in history. The company has raised all that cash and stayed private for years, even amidst the most prolonged and successful biotech IPO run in history. Unlike a typical biotech going public, Moderna has a pipeline of 21 programs, 10 of which are in human testing.

New Tech Tonics Podcast: Lisa Alderson and her Long and Winding Road to Genomics

Digital Health

Biotech and Genetics Diagnostics and Screening Digital Health Entrepreneurship Healthcare Information Technology Innovation Precision Medicine Tech Tonics Podcast Uncategorized connected social media david shaywitz GE Ventures genetic testing Genome Medical Genomic Health Invitae Lisa Alderson Lisa Suennen Randy Scott Tech Tonics telemedicine for genetic counseling

$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018

Lloyd Price

For many biotech companies, mergers and acquisitions have become a cornerstone in building a robust pipeline that can ensure positive growth for years to come. 2017 was considered to be a lean year for M&A in biotech. So far during the first six months of the year, more than $100 billion has been spent on a myriad of acquisitions across the pharma and biotech industries.

AMA teams up with biotech incubator to connect physicians with startups

FierceHealthIT

The American Medical Association is teaming up with Sling Health to give startup entrepreneurs access to physicians' perspectives on where technology can be applied to fix real-world clinical problems

New Episode of the Tech Tonics Podcast: Zoe Barry: Driving Entrepreneurship from the Fast Lane

Digital Health

Healthcare Information Technology Innovation Pharma/Biotech Tech Tonics Podcast Uncategorized connected social media david shaywitz Lisa Suennen specialty pharma digital health tech tonics podcast women mentorship ZappRx Zoe BarryWhen Zoe Barry was a kid, she had two things she wanted to be when she grew up, either a veterinarian or “someone who writes checks.” She gave the first a shot and ended up settling on the second.

Latest Tech Tonics Podcast: From Farm to Negotiating Table – James Dromey of the Murdoch Royal Children’s Institute

Digital Health

Biotech and Genetics David Shaywitz Digital Health Entrepreneurship Innovation Precision Medicine Tech Tonics Podcast Uncategorized connected social media david shaywitz Dr. James Dromey health system innovation James Dromey Lisa Suennen MCRI Murdoch Children's Research Institute Royal Children's Hospital Melbourne Tech Tonics translational medicineJames Dromey was supposed to be a farmer in County Cork, Ireland and has the milking experience to prove it.

The New Drug Companies Aren’t Drug Companies At All

Health Populi

” GNS has already been hard at work to build out those deep partnerships with health ecosystem stakeholders including health plans, health care providers, and pharma and biotech companies some of which are shown in the table. Artificial intelligence Big data and health Bio/life sciences Biotech Data analytics and health Health care industry Health ecosystem Health insurance Medicare Medicines Personalized medicine Pharmaceutical Venture capital and health

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

Biotech is roughly tied for second place with consumer health, dropping also by 7 points. There’s another piece of math worth doing here: a chasm between biotech and pharma of 17 percentage points worth of trust — that is the difference between the 55% of American trusting biotech versus 38% trusting pharma. In that context, look at chart #4, “Biotech Seen as the Laboratory vs Pharma.” In the U.S.,

Healthcare Companies Struggle With Implementing Digital Transformation

Healthcare IT Today

Administration C-Suite Leadership EMR-EHR Health IT Company Healthcare IT Hospital - Health System IT Biotech Companies Healhcare Digital Transformation Life Sciences Medtech Companies Pharmaceutical companies Simon-Kucher & Partners

In Health Tech, Beware of Getting Exactly What You Want

Healthcare IT Today

Last night, I watched a video about the rise and fall of disgraced biotech startup Theranos, which claimed to have invented technology that would dramatically change clinical blood testing worked. Ambulatory Clinical EMR-EHR Genomics-Precision Medicine Health IT Company Healthcare IT Biotech Startups Blood Testing Clinical Testing Health IT Investment Theranos Walgreens

LA BioMed closes $50M bond sale to finance biotech research lab

FierceHealthIT

LA BioMed, a nonprofit scientific research organization on the Harbor-UCLA Medical Center Campus, attracted more than twice the offering size of its first bond issue. Here's what they plan to do with it

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

Bio/life sciences Biotech Consumer experience Financial toxicity Health care industry Health Consumers Health costs Health Economics Health ecosystem Health policy Health politics Hospitals Medicare Medication adherence Medicines Money and health Pharmaceutical Physicians Prescription drugs Retail health Social determinants of health Specialty drugs TransparencyPeople in the U.S.

Don’t Blink: Healthcare Orgs Using AI, Data Analytics To Speed Up Digital Transformation

Healthcare IT Today

Over the next five years, healthcare and life sciences firms will ramp up their digital transformation efforts, driven at least in part by AI and data analytics tools, according to a recent research report.

Inanovate Inc. Secures $3.1 Million Investment To Support Breast Cancer Detection Technology

Electronic Health Reporter

Joni Johnson Kim Patrick Sanford Health South Dakota Biotech South Dakota Equity PartnersThis article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Inanovate, Inc., a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1million on a Series C financing round. The investment, led by South Dakota Equity Partners, Mr. T.